Chemoinformaics analysis of 16-Acetoxy-7alpha-methoxyroyleanone
| Molecular Weight | 404.503 | nRot | 4 |
| Heavy Atom Molecular Weight | 372.247 | nRig | 17 |
| Exact Molecular Weight | 404.22 | nRing | 3 |
| Solubility: LogS | -4.219 | nHRing | 0 |
| Solubility: LogP | 4.325 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 64.5594 |
| nHD | 1 | BPOL | 38.1786 |
| QED | 0.387 |
| Synth | 4.458 |
| Natural Product Likeliness | 1.95 |
| NR-PPAR-gamma | 0.718 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.941 |
| Pgp-sub | 0.004 |
| HIA | 0.071 |
| CACO-2 | -4.956 |
| MDCK | 0.0000248 |
| BBB | 0.067 |
| PPB | 0.990267 |
| VDSS | 2.25 |
| FU | 0.0410978 |
| CYP1A2-inh | 0.286 |
| CYP1A2-sub | 0.755 |
| CYP2c19-inh | 0.082 |
| CYP2c19-sub | 0.676 |
| CYP2c9-inh | 0.263 |
| CYP2c9-sub | 0.845 |
| CYP2d6-inh | 0.312 |
| CYP2d6-sub | 0.244 |
| CYP3a4-inh | 0.34 |
| CYP3a4-sub | 0.511 |
| CL | 4.972 |
| T12 | 0.41 |
| hERG | 0.025 |
| Ames | 0.042 |
| ROA | 0.186 |
| SkinSen | 0.757 |
| Carcinogencity | 0.165 |
| EI | 0.382 |
| Respiratory | 0.885 |
| NR-Aromatase | 0.8 |
| Antiviral | Yes |
| Prediction | 0.695009 |